bf/NYSE:BMY_icon.jpeg

NYSE:BMY

Bristol Myers Squibb

  • Stock

USD

Last Close

46.63

06/11 22:10

Market Cap

83.35B

Beta: 0.43

Volume Today

17.16M

Avg: 7.82M

PE Ratio

11.94

PFCF: 8.37

Dividend Yield

4.80%

Payout:57.08%

    Description

    Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.511.522017-07-272019-07-252021-07-282023-07-272025-02-07

    Revenue (Estimate*)

    2B4B6B8B10B12B2017-07-272019-07-252021-07-282023-07-272025-02-07

    *Estimate based on analyst consensus